Location: San Francisco, CA
CIK: 0001587114 · Show all filings
Period: Q3 2017 (← Previous) (Next →)
Filing Date: Nov 14, 2017
Total Value: $750M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ASSEMBLY BIOSCIENCES INC | 2,943,164 | $103M | 13.7% | $8.38 | — | COM | 045396108 |
| — | FIBROGEN INC | 1,735,677 | $93.38M | 12.4% | $33.98 | — | COM | 31572Q808 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 5,459,583 | $86.1M | 11.5% | $11.59 | +18.8% | COM | 46333X108 |
| ASND | ASCENDIS PHARMA A S | 2,107,600 | $76.4M | 10.2% | $26.79 | — | SPONSORED ADR | 04351P101 |
| KURA | KURA ONCOLOGY INC COM | 3,766,852 | $56.31M | 7.5% | $9.78 | -4.0% | COM | 50127T109 |
| — | IMMUNOMEDICS INC | 2,860,019 | $39.98M | 5.3% | $13.98 | — | COM | 452907108 |
| — | MYOKARDIA INC | 689,986 | $29.57M | 3.9% | $42.85 | — | COM | 62857M105 |
| GLPG | GALAPAGOS NV SPON ADR | 240,776 | $24.5M | 3.3% | $58.59 | — | SPONSORED ADR | 36315X101 |
| — | MARINUS PHARMACEUTICALS INC | 3,622,271 | $21.26M | 2.8% | $5.87 | — | COM | 56854Q101 |
| — | ATYR PHARMA INC | 3,934,849 | $19.87M | 2.6% | $3.81 | — | COM | 002120103 |
| — | TOCAGEN INC | 1,502,373 | $18.72M | 2.5% | $12.03 | — | COM | 888846102 |
| — | ARRAY BIOPHARMA INC | 1,250,000 | $15.38M | 2.0% | $12.30 | — | COM | 04269X105 |
| CTMX | CYTOMX THERAPEUTICS INC | 829,771 | $15.08M | 2.0% | $13.26 | +17.6% | COM | 23284F105 |
| CRVS | CORVUS PHARMACEUTICALS INC | 908,525 | $14.48M | 1.9% | $11.04 | +25.4% | COM | 221015100 |
| — | INTEC PHARMA LTD JERUSALEM | 1,500,000 | $13.43M | 1.8% | $8.95 | — | COM | M53644106 |
| INSM | INSMED INC | 405,400 | $12.65M | 1.7% | $19.05 | 0.0% | COM | 457669307 |
| WVE | WAVE LIFE SCIENCES LTD | 564,248 | $12.27M | 1.6% | $20.10 | 0.0% | COM | Y95308105 |
| — | CASCADIAN THERAPEUTICS INC | 3,000,000 | $12.27M | 1.6% | $4.14 | — | COM | 14740B606 |
| — | VERTEX PHARMACEUTICALS INC | 67,600 | $10.28M | 1.4% | — | — | Call | 92532F900 |
| — | IRONWOOD PHARMACEUTICALS INC | 620,000 | $9.777M | 1.3% | — | — | Call | 46333X908 |
| OMER | OMEROS CORP | 450,000 | $9.729M | 1.3% | $21.19 | 0.0% | COM | 682143102 |
| FATE | FATE THERAPEUTICS INC | 2,262,678 | $8.96M | 1.2% | $3.66 | -7.1% | COM | 31189P102 |
| — | REGULUS THERAPEUTICS INC | 5,239,225 | $6.549M | 0.9% | $1.25 | — | COM | 75915K101 |
| — | DICERNA PHARMACEUTICALS INC | 957,992 | $5.508M | 0.7% | $3.77 | — | COM | 253031108 |
| — | OVASCIENCE INC | 3,512,332 | $4.988M | 0.7% | $1.87 | — | COM | 69014Q101 |
| ZLAB | ZAI LAB LIMITED | 159,535 | $4.307M | 0.6% | $27.00 | — | SPONSORED ADR | 98887Q104 |
| — | KINDRED BIOSCIENCES INC | 544,880 | $4.277M | 0.6% | $7.10 | — | COM | 494577109 |
| SGMO | SANGAMO BIOSCIENCES INC | 222,388 | $3.336M | 0.4% | $6.42 | +72.3% | COM | 800677106 |
| — | CLEMENTIA PHARMACEUTICALS INC | 194,166 | $3.279M | 0.4% | $16.89 | — | COM | 185575107 |
| — | ADVERUM BIOTECHNOLOGIES INC | 762,947 | $2.785M | 0.4% | $4.11 | — | COM | 00773U108 |
| — | CLOVIS ONCOLOGY INC | 25,765 | $2.123M | 0.3% | $86.75 | — | COM | 189464100 |
| XNCR | XENCOR INC | 90,114 | $2.065M | 0.3% | $22.20 | 0.0% | COM | 98401F105 |
| — | SEATTLE GENETICS INC | 30,000 | $1.632M | 0.2% | $53.07 | — | COM | 812578102 |
| ACRS | ACLARIS THERAPEUTICS INC | 60,000 | $1.549M | 0.2% | $26.78 | +0.1% | COM | 00461U105 |
| — | SYROS PHARMACEUTICALS INC | 104,000 | $1.531M | 0.2% | $14.72 | — | COM | 87184Q107 |
| BMY | BRISTOL MYERS SQUIBB CO | 17,060 | $1.087M | 0.1% | $39.73 | +8.5% | COM | 110122108 |
| ONC | BEIGENE LTD SPONSORED ADR | 9,800 | $1.009M | 0.1% | $102.96 | — | SPONSORED ADR | 07725L102 |
| — | DECIPHERA PHARMACEUTICALS INC | 45,000 | $855K | 0.1% | $19.00 | — | COM | 24344T101 |
| — | SPRING BK PHARMACEUTICALS INC | 16,000 | $269K | 0.0% | $16.81 | — | COM | 849431101 |